TY  - CONF

T1  - Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study

JO  - Poster Session Abstracts

PY  - 2020/02/15

AU  - Stavraka C

AU  - Evans TRJ

AU  - Dunlop J

AU  - Earl H

AU  - Cameron DA

AU  - Coleman RE

AU  - Perren T

AU  - Leonard RCF

AU  - Mansi JL

ED  - 

DO  - DOI: 10.1158/1538-7445.sabcs19-p2-16-15

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -